Literature DB >> 6439947

A survey of the pathology of marmosets (Callithrix jacchus) under experiment.

M J Tucker.   

Abstract

A survey of the pathology of 567 laboratory-bred cotton-eared marmosets (Callithrix jacchus) is presented. There were few significant pathological changes in animals used in studies up to 6 months in duration, suggesting that the marmoset can be a useful non-human primate species for routine toxicology. The most common pathological changes encountered were chronic colitis, chronic thyroiditis and interstitial mononuclear infiltration in the kidney. No internal parasites were encountered, nor were any viral or bacterial diseases identified. Fungal disease was confined to a few cases of oesophageal mycoses. In a long term study a variety of pathological changes have been observed, including a 'wasting' syndrome, not related to skeletal muscle myopathy, with atrophy of the gastrointestinal tract, salivary glands and gonads, haemosiderosis and fatty change in the liver and osteoporosis. It is suggested that these changes may be related to protein deficiency and that the nutritional requirements of the marmoset require further investigation.

Entities:  

Mesh:

Year:  1984        PMID: 6439947     DOI: 10.1258/002367784780865397

Source DB:  PubMed          Journal:  Lab Anim        ISSN: 0023-6772            Impact factor:   2.471


  16 in total

1.  Fecal Concentrations of N-methylhistamine in Common Marmosets (Callithrix jacchus).

Authors:  Joseph Cyrus Parambeth; Franklin R López; Rosana Lopez; Sarah B Keyser; Jonathan A Lidbury; Jan S Suchodolski; Jörg M Steiner
Journal:  Comp Med       Date:  2019-02-25       Impact factor: 0.982

2.  Purification and partial characterization of α1-proteinase inhibitor in the common marmoset (Callithrix jacchus).

Authors:  Joseph Cyrus Parambeth; Jan S Suchodolski; Jörg M Steiner
Journal:  Res Vet Sci       Date:  2015-02-11       Impact factor: 2.534

3.  Serum Cobalamin and Folate Concentrations in Common Marmosets (Callithrix jacchus) with Chronic Lymphocytic Enteritis.

Authors:  Joseph Cyrus Parambeth; Corinna N Ross; Andrew D Miller; Steven N Austad; Jonathan A Lidbury; Jan S Suchodolski; Jörg M Steiner
Journal:  Comp Med       Date:  2019-03-22       Impact factor: 0.982

4.  The Common Marmoset-Biomedical Research Animal Model Applications and Common Spontaneous Diseases.

Authors:  Hyo-Jeong Han; Sarah J Powers; Kathleen L Gabrielson
Journal:  Toxicol Pathol       Date:  2022-05-10       Impact factor: 1.930

5.  Treatment of giardiasis in common marmosets (Callithrix jacchus) with tinidazole.

Authors:  Joshua A Kramer; Audra M Hachey; Lynn M Wachtman; Keith G Mansfield
Journal:  Comp Med       Date:  2009-04       Impact factor: 0.982

6.  Spontaneous pathology of the common marmoset (Callithrix jacchus) and tamarins (Saguinus oedipus, Saguinus mystax).

Authors:  John M David; Edward J Dick; Gene B Hubbard
Journal:  J Med Primatol       Date:  2009-06-10       Impact factor: 0.667

7.  Spontaneous (Hashimoto-like) chronic lymphocytic thyroiditis in a rhesus macaque (Macaca mulatta).

Authors:  Roland Plesker; Gudrun Hintereder
Journal:  Primate Biol       Date:  2021-06-01

8.  Detection of calprotectin and apoptotic activity in the colon of marmosets with chronic diarrhea.

Authors:  Erika Nakashima; Yasushi Okano; Kimie Niimi; Eiki Takahashi
Journal:  J Vet Med Sci       Date:  2013-07-24       Impact factor: 1.267

Review 9.  Research Relevant Conditions and Pathology in Nonhuman Primates.

Authors:  Chandra Saravanan; Thierry Flandre; Carolyn L Hodo; Anne D Lewis; Lars Mecklenburg; Annette Romeike; Oliver C Turner; Hsi-Yu Yen
Journal:  ILAR J       Date:  2020-12-31       Impact factor: 1.521

10.  Serum albumin and body weight as biomarkers for the antemortem identification of bone and gastrointestinal disease in the common marmoset.

Authors:  Victoria K Baxter; Gillian C Shaw; Nathaniel P Sotuyo; Cathy S Carlson; Erik J Olson; M Christine Zink; Joseph L Mankowski; Robert J Adams; Eric K Hutchinson; Kelly A Metcalf Pate
Journal:  PLoS One       Date:  2013-12-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.